Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Thyroid Gland01:23

The Thyroid Gland

4.1K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
4.1K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

4.8K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

598
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
598
Cancer Therapies02:49

Cancer Therapies

7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

2.9K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
2.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anaplastic thyroid cancer: Cases, incidence, prevalence and survival in Germany.

Endocrine·2026
Same author

State-of-the-Art Theranostics of Thyroid Cancer.

PET clinics·2026
Same author

Thyroid Cancer: Epidemiology, Diagnosis, and Treatment.

Deutsches Arzteblatt international·2026
Same author

First αvβ6-integrin targeted radioligand therapy of breast cancer using Lu-177-Therahexin.

European journal of nuclear medicine and molecular imaging·2026
Same author

[Novel imaging techniques for the differential diagnosis of adrenal tumors, pheochromocytomas and paragangliomas].

Chirurgie (Heidelberg, Germany)·2026
Same author

Advancements in Renal Imaging: A Comprehensive Systematic Review of PET Probes for Enhanced GFR and Renal Perfusion Assessment.

Diagnostics (Basel, Switzerland)·2025
Same journal

Laryngo- rhino- otologie·2026
Same journal

Laryngo- rhino- otologie·2026
Same journal

Laryngo- rhino- otologie·2026
Same journal

[Otitis media - update on clinical presentation, diagnosis and therapy].

Laryngo- rhino- otologie·2026
Same journal

[Diagnostic error "acute otitis media"].

Laryngo- rhino- otologie·2026
Same journal

[Pharyngeal high‑resolution manometry: techniques and applications].

Laryngo- rhino- otologie·2026
See all related articles

Related Experiment Video

Updated: Aug 4, 2025

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

577

[Therapy concepts for thyroid carcinoma].

Friederike Eilsberger1, Michael C Kreissl2, Markus Luster3

  • 1Klinik für Nuklearmedizin, Universitätsklinikum Marburg, Marburg, Germany.

Laryngo- Rhino- Otologie
|April 3, 2023
PubMed
Summary
This summary is machine-generated.

Theranostics targeting the sodium iodide symporter (NIS) are effective for differentiated thyroid cancer. However, radioiodine-refractory thyroid carcinomas (RRTC) lack NIS, necessitating novel theranostic targets for improved treatment outcomes.

More Related Videos

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

3.8K
Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.7K

Related Experiment Videos

Last Updated: Aug 4, 2025

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

577
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

3.8K
Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.7K

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Molecular Imaging

Context:

  • Differentiated thyroid carcinoma (DTC) management relies on sodium iodide symporter (NIS) theranostics.
  • Radioiodine-refractory thyroid carcinomas (RRTC) present a therapeutic challenge due to absent NIS expression.
  • Limited treatment options for RRTC necessitate the development of alternative theranostic strategies.

Purpose:

  • To explore the potential of novel theranostic targets in NIS-negative RRTC.
  • To evaluate the feasibility of targeting somatostatin receptors (SSTR) and prostate-specific membrane antigen (PSMA) in RRTC.
  • To assess the current evidence for emerging theranostic approaches in advanced thyroid cancer.

Summary:

  • The sodium iodide symporter (NIS) is a key theranostic target in differentiated thyroid carcinoma.
  • Radioiodine-refractory thyroid carcinomas (RRTC) are characterized by reduced or absent NIS expression, rendering standard theranostics ineffective.
  • Emerging strategies involve targeting alternative receptors like somatostatin receptors (SSTR) or prostate-specific membrane antigen (PSMA) in RRTC, though further evaluation is required.

Impact:

  • This research highlights the limitations of current theranostics in RRTC.
  • It identifies potential new theranostic targets for a challenging subset of thyroid cancer.
  • Further investigation into SSTR and PSMA targeting could lead to improved therapeutic outcomes for patients with RRTC.